Reducing CSF methionine levels as a treatment approach to methionine-addicted tumor cells might be more difficult in the context of gliomas due to the role of LAT1 in the delivery of methionine to the tumor microenvironment. Here, SLC7A5 is linked to central nervous system cancer.